1996
DOI: 10.1183/09031936.96.09071445
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of tachykinin NK<SUB>1</SUB> and NK<SUB>2</SUB> receptors in substance P-induced microvascular leakage hypersensitivity and airway hyperresponsiveness in guinea-pigs

Abstract: Involvement of tachykinin NK 1 and NK 2 receptors in substance P-induced microvascular leakage hypersensitivity and airway hyperresponsiveness in guinea-pigs. E. Boichot, K. Biyah, N. Germain, X. Emonds-Alt, V. Lagente, C. Advenier. ©ERS Journals 1996. ABSTRACT: Tachykinins, such as substance P, might be involved in the development of airway hyperresponsiveness (AHR) and airway inflammation. However, it is unknown which tachykinin receptors mediate these biological activities. The effects of two antagonists o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
14
0

Year Published

1997
1997
2021
2021

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 23 publications
(16 citation statements)
references
References 34 publications
2
14
0
Order By: Relevance
“…Inhaled SP in phosphoramidon-pretreated guinea-pig also induced bronchial hyperresponsiveness [49]. In this model again, SR 48968, but not SR 140333, suppressed the leftward shift of the dose-response curve to acetylcholine observed after exposure of phosphoramidon-pretreated guineapigs to SP [67], and these data also support a role for tachykinin NK 2 receptor stimulation in the development of airway hyperresponsiveness. Similar conclusions were reported by YOSHIHARA et al [68], who showed that SR 48968 prevented the potentiation of antigen-induced bronchoconstriction by cold air in guinea-pigs; and by PERRETTI et al [69], who reported that the specific and long-acting peptidic antagonist, MEN 10,627, inhibited PAF-induced airway hyperresponsiveness in the guineapig.…”
Section: Tachykinin Receptor Antagonists and Bronchial Hyperresponsivsupporting
confidence: 59%
See 2 more Smart Citations
“…Inhaled SP in phosphoramidon-pretreated guinea-pig also induced bronchial hyperresponsiveness [49]. In this model again, SR 48968, but not SR 140333, suppressed the leftward shift of the dose-response curve to acetylcholine observed after exposure of phosphoramidon-pretreated guineapigs to SP [67], and these data also support a role for tachykinin NK 2 receptor stimulation in the development of airway hyperresponsiveness. Similar conclusions were reported by YOSHIHARA et al [68], who showed that SR 48968 prevented the potentiation of antigen-induced bronchoconstriction by cold air in guinea-pigs; and by PERRETTI et al [69], who reported that the specific and long-acting peptidic antagonist, MEN 10,627, inhibited PAF-induced airway hyperresponsiveness in the guineapig.…”
Section: Tachykinin Receptor Antagonists and Bronchial Hyperresponsivsupporting
confidence: 59%
“…In these conditions, SR 140333 has been shown to markedly reduce the SP-induced potentiation of microvascular leakage induced by histamine, whereas SR 48968 had no preventative effects [67]; strengthening the role of the tachykinin NK 1 receptor in the microvascular leakage following tachykinin stimulation. Similar results were obtained in animals exposed to aerosolized citric acid and challenged 24 h later with histamine [93].…”
Section: Tachykinins and Microvascular Leakagementioning
confidence: 91%
See 1 more Smart Citation
“…Furthermore, antagonizing the NK 1 receptor has no influence on the increased activation status of alveolar macrophages after ovalbumin challenge in sensitized guinea pigs, suggesting no effect of the NK 1 receptor on the activation of macrophages in ovalbumin-sensitized and ovalbumin-exposed animals. 11 We did not observe any induced hyperresponsiveness in our model, although others did report allergen-induced hyperresponsiveness in mice, 21,22 guinea pigs, 23,24 and rats. 25 Therefore, no conclusions about the role of the NK 1 receptor in allergen-induced hyperresponsiveness could be made.…”
Section: Discussionmentioning
confidence: 73%
“…Also, NK 2 but not NK 1 antagonists have been shown to reduce allergen–induced AHR at 24 and 48 h after allergen challenge [6]. Boichot et al [16]showed that NK 1 antagonists inhibited the increase of microvascular leakage of histamine in SP–exposed guinea pigs, but did not prevent the development of AHR, and suggested a lack of association between the presence of microvascular leakage and the occurrence of AHR. Advenier et al [12]suggested that NK 1 mediated the development of microvascular leakage hypersensitivity, whille NK 2 mediated the development of AHR by exposure to SP or citric acid in guinea pigs, and that NK 2 receptor stimulation plays an important role in the development of AHR, while the effects of NK 1 receptor antagonists are still being debated.…”
Section: Discussionmentioning
confidence: 99%